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OBJECTIVE: The purpose of this study was to evaluate the effectiveness of contrast-enhanced ultrasound with a
second-generation contrast agent in distinguishing between occlusion and pseudo-occlusion of the cervical
internal carotid artery, comparing it with that of conventional Doppler ultrasound and the gold standard,
computed tomography angiography.
METHOD: Between June 2006 and June 2012, we screened 72 symptomatic vascular surgery outpatients at a
public hospital. Among those patients, 78 cervical internal carotid arteries were previously classified as occluded
by Doppler ultrasound (without contrast). The patients were examined again with Doppler ultrasound, as well
as with contrast-enhanced ultrasound and computed tomography angiography. The diagnosis was based on
the presence or absence of flow.
RESULTS: Among the 78 cervical internal carotid arteries identified as occluded by Doppler ultrasound,
occlusion was confirmed by computed tomography angiography in only 57 (73.1%), compared with 59 (77.5%)
for which occlusion was confirmed by contrast-enhanced ultrasound (p.0.5 vs. computed tomography
angiography). Comparing contrast-enhanced ultrasound with Doppler ultrasound, we found that the
proportion of cervical internal carotid arteries classified as occluded was 24.4% higher when the latter was
used (p,0.001).
CONCLUSIONS: We conclude that, in making the differential diagnosis between occlusion and pseudo-
occlusion of the cervical internal carotid artery, contrast-enhanced ultrasound with a second-generation
contrast agent is significantly more effective than conventional Doppler ultrasound and is equally as effective
as the gold standard (computed tomography angiography). Our findings suggest that contrast-enhanced
ultrasound could replace computed tomography angiography in this regard.
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& INTRODUCTION
Extracranial carotid artery stenosis can cause neurological
symptoms such as stroke (brain attack), which is one of the
leading causes of morbidity and mortality worldwide (1).
Carotid stenosis causes cerebral microembolization to the
brain and occlusion is usually interpreted as the cessation of
the risk of embolic events; thus, no surgical treatment is
required. However, in rare cases (2-8% of cases annually),
Copyright  2015 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.




carotid occlusion or pseudo-occlusion continues to cause
neurological symptoms, despite the appropriate medical
treatment (2).
Although digital subtraction angiography (DSA) is the
gold standard method for evaluating stenosis of the internal
carotid artery (ICA), the procedure is invasive and is
associated with a considerable risk of post-procedure
neurological complications (3). Previous reports have
established that computed tomography angiography
(CTA) is nearly as accurate as DSA and can also be
considered as the gold standard for evaluating such cases
(4-6). However, CTA is not without adverse affects, given
that it involves the use of ionizing radiation and iodinated
contrast media (3).
Conventional ultrasound (Doppler US) is 95-99% accurate
for detecting ICA stenosis, even when there is a high degree
of stenosis (7,8). However, when evaluated by Doppler US,
some symptomatic patients with near-occlusion stenosis,
usually associated with very low flow, are wrongly
classified as having occlusion (9,10). The establishment of
a safer, simpler, cost-effective and readily available imaging
methods capable of more accurately confirming or exclud-
ing a diagnosis of occlusion would facilitate decisions
regarding the ideal treatment (2,7). Contrast-enhanced
ultrasound (CEUS) has been shown to be effective in
distinguishing between occlusion and pseudo-occlusion of
the ICA (6,9,11-14). Microbubble contrast agents substan-
tially increase the ultrasound reflectivity in the bloodstream,
thus increasing the diagnostic accuracy (15). The first
generation of such contrast agents comprised microbubbles
that were filled with air and were consequently very short-
lived, which limited their clinical utility (16,17). The second
generation of microbubble contrast agents used inert gases
such as fluorocarbons, which are more stable, thereby
prolonging the lifespan of the microbubbles in the blood-
stream (#10 min) and improving the sensitivity of the
ultrasound (16,17). Microbubbles filled with such gases
have diameters ranging from 1 to 10 mm (16,17), approx-
imating the diameter of a red blood cell (7 mm).
The main objective of this study was to evaluate the
effectiveness of CEUS with a second-generation contrast
agent in distinguishing between occlusion and pseudo-
occlusion of the cervical ICA, comparing it with that of
Doppler US. To test the diagnostic power of the CEUS
approach, we also compared it with CTA.
& MATERIALS AND METHODS
This was a prospective study conducted between June
2006 and June 2012 at the Hospital das Clı´nicas da
Faculdade de Medicina da Universidade de Sa˜o Paulo
(HCFMUSP, University of Sa˜o Paulo School of Medicine
Hospital das Clı´nicas) in the city of Sa˜o Paulo, Brazil. The
study was approved by the Hospital das Clı´nicas da
Faculdade de Medicina da Universidade de Sa˜o Paulo
Research Ethics Committee.
The study sample comprised consecutive patients with
suspected ICA occlusion followed at the Hospital das
Clı´nicas da Faculdade de Medicina da Universidade de
Sa˜o Paulo Vascular Surgery Clinic and referred for
confirmatory diagnosis between June 2006 and June 2012.
We screened 72 symptomatic vascular surgery outpatients
treated at HC-FMUSP who presented with 78 ICAs that
were previously classified as occluded by Doppler US
(without contrast) at another facility.
Those patients were again examined by Doppler US, as
well as by CEUS and CTA. Doppler US was performed by a
radiologist with extensive training in the use of this imaging
method. CEUS, aimed at identifying pseudo-occlusion by
studying the residual lumen, was performed by that same
radiologist. CTA was used as the reference standard and the
results were evaluated by two other radiologists, each with
ten years of experience, both of whom were blinded to the
evaluation made by the other, as well as to the CEUS results.
When there was disagreement between the two CTA
evaluators, the diagnosis was made by consensus.
Ultrasound
For Doppler US and CEUS, we used high-resolution
ultrasound instruments (HDI 5000 and IU 22; ATL-Philips
Medical Systems, Bothell, WA, USA). Depending upon the
biotype and the anatomy of the cervical carotid arteries of
the patient, we used linear array transducers (7.0-12.0 MHz)
or convex array transducers (3.5-7.0 MHz). The processing
parameters of the ultrasound device were exclusively
adjusted to evaluate the specific peripheral vessels of the
cervical carotid arteries in the Doppler US and CEUS
examinations. To optimize the acoustic properties of the
contrast agent in CEUS, we used tissue harmonic imaging
and pulse inversion harmonic imaging. Patients were
evaluated in a supine position with extension and contral-
ateral rotation of the head toward the carotid segment being
studied. We thoroughly evaluated the ICA from its
emergence and bifurcation to the most distal ends, using
linear or convex transducers as required.
In the initial evaluation of the ICA, as well as in the
investigation of the presence of material occupying the
vessel lumen, we used Doppler US in B mode. To quantify
the blood flow within the ICA, we used conventional color
and power color Doppler US, as well as pulsed Doppler US
(Figure 1).
In the CEUS, we employed the second-generation micro-
bubble contrast agent perfluorocarbon-exposed sonicated
dextrose albumin (PESDA), manufactured in the Radiology
Laboratory of the FMUSP. We chose to use our own PESDA
rather than a commercial contrast agent to minimize costs.
Figure 1 - Color Doppler ultrasound demonstrating the absence
of flow in the internal carotid artery (ICA).
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We produced PESDA using the technique described by
Porter et al. (18). In brief, a solution of 5% dextrose was
mixed with a solution of 5% human albumin and
decafluorobutane gas was added to the mixture. Each
patient received a bolus injection of PESDA (3 ml) into a
peripheral vein, followed by a 10-ml saline flush. As
observed in Figures 2 and 3, the CEUS study with the
microbubble contrast agent was combined with conven-
tional color and power color Doppler US to increase the
intensity of the flow signal and to facilitate the characteriza-
tion of residual flow in the ICA (11,13), although this aspect
was not included in our statistical analysis. The images were
analyzed with a focus on flow in the interior of the ICA. All
examinations were digitally recorded (in AVI, JPEG and
MPEG formats) for subsequent analysis.
The CTA, as illustrated in Figure 4, was performed with a
multidetector helical CT scanner (MX 8000; Philips Medical
Systems), in slices #0.6 mm, at a reconstruction interval of
0.5 mm. Slices were acquired from top to bottom to
minimize venous contamination after the injection of non-
ionic iodinated contrast, which was administered to the
patients in a dose of 2.5 ml/kg at a flow rate of 4 ml/s to a
maximum of 100 ml. To guarantee uniform and adequate
flow, the CTA contrast agent was administered with an
injection pump and all examinations were supervised by a
radiologist experienced in bolus tracking. During the
contrast injection, we acquired short, fixed tomographic
slices of the carotid bodies showing a rising curve based on
the Hounsfield (HU) units ($150 HU). The examinations
were post-processed on a CT workstation (Brilliance; Philips
Medical Systems) and all examinations were double-read by
the two radiologist evaluators. After the examinations were
finished, the results were compared to perform the tests
described below.
Statistics
Diagnostic measurements were evaluated to calculate the
sensitivity, specificity, positive predictive value, negative
predictive value and accuracy. For each value, we calculated
the 95% confidence interval (95% CI) using Confidence
Interval Analysis software, version 2.1.2 (http://www.som.
soton.ac.uk/cia/). McNemar’s chi-square test was used to
compare the proportion of positive results between two
types of examinations. Statistical analysis was performed
with the Statistical Package for the Social Sciences, version
16.0 for Windows (SPSS Inc., Chicago, IL, USA). Values of
p,0.05 were considered statistically significant.
& RESULTS
We included 72 patients examined at the HC-FMUSP
between June 2006 and June 2012. The mean age¡ standard
deviation of the patients was 67¡11 years (range, 41-96
years). Of the 72 patients, 57 (79.2%) were male. Previous
examinations with Doppler US had identified right ICA
occlusion in 31 patients, left ICA occlusion in 41 and
bilateral ICA occlusion in 6. Therefore, we evaluated a total
of 78 carotids.
Comparing the Doppler US results with those of the CTA
(Table 1), we found that the use of the former resulted in a
false-positive diagnosis of ICA occlusion in 21 of the 78
evaluated carotids (26.9%; 95% CI: 17.5-38.2%; p,0.001), a
finding that is in accordance with previous reports (9,10).
Therefore, there was concordance between the two methods
Figure 2 - Contrast-enhanced ultrasound (CEUS) characterizing
residual flow in the internal carotid artery (ICA).
Figure 3 - Residual flow of the internal carotid artery (ICA), as
characterized by contrast-enhanced ultrasound (CEUS) in asso-
ciation with power color Doppler.
Figure 4 - Computed tomography angiography (CTA) confirming
the presence of residual flow in the internal carotid artery (ICA).
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in only 57 of the 78 carotids (73.1%; 95% CI: 61.8-82.5%). The
difference between CEUS and Doppler US was also
significant (p,0.001). However, comparing the CTA results
with the CEUS results (Table 2), we found no significant
difference between the two methods, with the latter
classifying 59 (77.5%) of the 78 carotids evaluated as
occluded (p,0.5).
Therefore, the false-positive rate for CEUS was 2.6% (2/
78) and there were no false negatives. We calculated the
sensitivity of CEUS to be 100% (95% CI: 95.4-100%), whereas
we found the specificity to be 90.5% (95% CI: 74.9-96.8%);
the positive predictive value was 96.6%, the negative
predictive value was 100% and the accuracy was 97.4%
(95% CI: 91.0-99.7%).
& DISCUSSION
Information about the residual lumen in symptomatic
patients suspected of ICA occlusion facilitates decisions
regarding the ideal treatment, be it clinical or surgical (2),
thereby improving the prognosis and preventing neurologic
symptoms along with the cessation of embolic events. Many
authors agree that Doppler US can lead to a considerable
number of false diagnoses of occlusion (4,5,8,9,20,21). The
imaging methods currently used in the diagnosis of ICA
occlusion—DSA, CTA and magnetic resonance imaging
(MRI)—are undoubtedly accurate (4,21-24) and DSA has
typically been considered as the gold standard (3,22,23). In
similar studies (6,9,12,13,19), DSA has been used as the gold
standard, or the reliability of CEUS has been compared with
that of MRI. However, CTA has been shown to have
excellent sensitivity and specificity for the diagnosis of ICA
occlusion (4,5), showing a rate of 100% for stenosis near
occlusion and 100% concordance with DSA (4), with the
added advantage of being a less invasive method. Because
of those considerations, together with its superiority over
MRI, CTA has been accepted as the new gold standard (4,5).
This led us to choose CTA to test the power of the CEUS
approach. As previously stated, the use of microbubble
contrast agents substantially increases the intensity of the
ultrasound blood flow signals (15) and CEUS has been
identified as preferable to Doppler US in various situations,
even in cases of suspected ICA occlusion (6,9,11,12,14). Our
study has confirmed that CEUS with a second-generation
contrast agent is reliable in the diagnosis of ICA occlusion,
being similar to CTA in terms of its sensitivity, specificity
and accuracy, increasing the already remarkable accuracy of
Doppler US in cases of pseudo-occlusion of the ICA.
Our findings corroborate those of other authors, who also
found CEUS to be a reliable method that is superior to
Doppler US in distinguishing between occlusion and
pseudo-occlusion of the ICA (6,9,11,12,14), although the
authors of one such study found no significant difference
between the two methods (13). However, those studies
involved patient samples that were smaller than the sample
evaluated in the present study and the latter study involved
the use of a first-generation contrast agent, as have other
such studies (6,9,12,19,25).
Some of those studies also included patients with known
pseudo-occlusion of the ICA (6,13); our study did not.
One interesting aspect of our study was that, unlike the
authors of some other studies (11,13), we used color and
power Doppler to increase the intensity of the flow signal in
CEUS, thus facilitating and speeding up the detection of
slow flow in the residual lumen. Although we believe that
to be advantageous, we found no subjective difference
between the accuracy of CEUS alone and that of CEUS
associated with color and power Doppler. It is notable that
this aspect was not included in our statistical analysis or in
the final results of our study. We also found that CEUS was
more reliable that Doppler US, even when the latter was
used in combination with power Doppler. In contrast, Furst
et al. (19) found no significant difference in the accuracy
between power Doppler and CEUS and concluded that
CEUS produces a better result only when compared with
Doppler US alone. However, it should be kept in mind that
power Doppler has a high mechanical index, which can be
deleterious to the patient; thus, extra care is highly recom-
mended. As for ultrasound with and without contrast agents,
the use of a convex array transducer (4.0-8.0 MHz)was highly
relevant to our study; this made it easier to evaluate the ICA,
which was clearly visualized even in its most distal segments,
allowing for the diagnosis of pseudo-occlusions that would
Table 1 - Distribution of the 78 internal carotid arteries classified as occluded by Doppler ultrasound (without contrast),
according to the computed tomography angiography results.
Computed tomography angiography
Doppler ultrasound (no contrast) Occlusion No occlusion Total
(n) (n)
Occlusion (n) 57 21 78
No occlusion (n) - - -
Total 57 21 78
Table 2 - Comparison between contrast-enhanced ultrasound and computed tomography angiography in the
evaluation of the 78 internal carotid arteries classified as occluded by Doppler ultrasound (without contrast).
Computed tomography angiography
Contrast-enhanced ultrasound Occlusion No occlusion Total
(n) (n)
Occlusion (n) 57 2 59
No occlusion (n) - 19 19
Total 57 21 78
CEUS vs. CTA in diagnosing ICA occlusion
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definitely not have been possible using only a linear
transducer.
Although it was not the focus of our study, we noticed
that CEUS is also useful in evaluating the appearance of the
ICA even in its most distal segments, allowing for the
assessment of poststenotic dilatation and of possible
sequential stenoses, as well as making it possible to
determine whether the vessel is a candidate for endarter-
ectomy (9). As previously demonstrated (6,12,26), CEUS
facilitates the determination of flow in highly calcified
vessels and provides a brighter view of unstable plaque
surfaces, making it easier to diagnose ulcerations. In cases of
pseudo-occlusion of the ICA, CEUS can better describe the
shape of the residual lumen, as we observed in the present
study, in which some of the residual lumina presented the
‘‘candle flame’’ shape (2). That residual lumen shape
facilitates the placement of the catheter to thread the
guide-wire in an endovascular procedure for the clearance
of obstruction (2). Therefore, we can infer that CEUS
facilitates therapeutic planning by allowing not only an
accurate differential diagnosis between occlusion and
pseudo-occlusion of the ICA but also a proper evaluation
of the morphology of the residual lumen. This observation
could become a topic for further studies.
Recent multicenter studies evaluating large patient
samples have clearly demonstrated that there is no addi-
tional risk associated with ultrasound studies involving
microbubble contrast agents (27,28). Although there have
been reports of pain or paresthesia at the puncture point,
lumbar pain, and (in rare cases) allergic reactions, as well as
damage to microcirculation (29), the patients in our study
showed no significant adverse reactions to the microbubble
contrast medium, exhibiting the same good tolerance
reported in the aforementioned studies (27,28). To reduce
the bioeffects of the contrast agent, we used a low
mechanical index (#0.4), low-frequency transducers and
short acoustic exposure times, as recommended by Barnett
et al. (29). In the present study, none of the 72 patients who
underwent CTA had any adverse reactions to the iodinated
contrast media, indicating good tolerance to the contrast
medium; this is also in agreement with the findings of other
authors (30,31).
Because of recent advances in the sensitivity of Doppler
US equipment, the vast majority of patients with ICA
stenosis, regardless of the degree, can be properly diag-
nosed. The use of CEUS has been reserved for symptomatic
patients in whom Doppler US raises the suspicion of
occlusion. Although correlation with the surgical procedure
would be desirable, only a few of our patients underwent
surgery after being diagnosed with pseudo-occlusion. One
unfavorable aspect of CEUS in relation to multi-planar
examinations is that it limits the evaluation of the
intracranial part of the ICA and of the vessels leading to it
(the aorta, the brachiocephalic artery and the common
carotid artery).
To the best of our knowledge, to date, this study involved
the largest patient sample in which CEUS with a second-
generation contrast agent has been evaluated as a means of
distinguishing between occlusion and pseudo-occlusion of
the cervical ICA.
In that regard, we concluded that CEUS is superior to
conventional Doppler US and is similar to CTA. Taken
together, our data suggest that CEUS can now supplant CTA
as the gold standard for the diagnosis of ICA occlusion.
Our findings suggest that symptomatic patients in whom
Doppler US indicates ICA occlusion should undergo CEUS
to confirm the diagnosis rather than undergoing invasive
examinations, which are more costly and more likely to
provoke adverse reactions. In addition, CEUS can be an
alternative for patients with kidney problems who cannot be
screened with either the iodinated contrast media used in
CTA and DSA or the gadolinium chelate used in MRI
angiography. Furthermore, in patients with a recent pattern
of ipsilateral transient ischemic attack, the use of CEUS
could facilitate decisions regarding treatments such as
endarterectomy or angioplasty with stent placement (2).
Our findings are quite encouraging and corroborate with
data in the literature regarding the accuracy of CEUS in
distinguishing between occlusion and pseudo-occlusion of
the ICA. However, it must be kept in mind that ultrasound
is an operator-dependent method and should therefore be
performed by experienced physicians or sonographers with
the use of appropriate equipment.
To conclude, CEUS with a second-generation contrast
agent is another alternative method by which radiologists
and vascular surgeons can accurately confirm or exclude a
diagnosis of ICA occlusion. That information could then
facilitate decisions regarding the ideal treatment.
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